Moelis & Co (MC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | |
| Stock-based compensation | 220.10M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 289.65M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $220.10M | $289.65M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $216.24M | $277.45M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $230.26M | $273.86M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | (m) | $206.72M | $277.37M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | $203.35M | $244.62M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $187.70M | $204.06M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $161.44M | $172.94M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | $155.73M | $32.09M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $150.91M | $-3.50M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | $158.53M | $-33.16M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $158.19M | $-40.35M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | $157.37M | $-1.58M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | $154.23M | $53.50M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $151.51M | $125.28M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $128.94M | $216.10M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | $155.88M | $339.78M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $155.86M | $456.88M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $154.04M | $512.90M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $167.94M | $495.92M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $144.72M | $549.27M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $145.99M | $449.08M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $146.33M | $313.71M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $133.62M | $265.71M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $124.43M | $76.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $124.71M | $78.33M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $123.58M | $129.36M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $124.21M | $114.54M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $131.77M | $160.95M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $131.83M | $159.57M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | $129.68M | $181.34M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $123.04M | $226.78M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | $112.16M | $202.29M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $104.90M | $189.25M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $102.64M | $176.32M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $96.30M | $164.28M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | $93.65M | $187.15M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $88.07M | $187.38M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $86.26M | $175.23M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $77.05M | $161.09M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $69.11M | $143.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $64.32M | $142.80M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $54.27M | $145.01M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $46.13M | $137.50M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $40.37M | $139.41M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $34.04M | $135.27M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $117.30M | $45.19M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $119.76M | $47.74M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $49.36M | $70.11M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $42.04M | $38.05M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.